Global Flu Vaccine Market is estimated to be US$ 8179.4 million by 2030 with a CAGR of 8.1% during the forecast period


Posted December 6, 2021 by Neha_sgk

" Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years),”
 
The Global Flu Vaccine Market accounted for US$ 4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is anticipated to register a CAGR of 6.0%. Influenza virus is continuously circulating causing regional epidemics and outbreaks, leading to thousands of deaths. For instance, according to Centers for Disease Control and Prevention (CDC) more than 13 million flu cases are recorded so far in the time-frame of 2019-20. World Health Organization (WHO) recommended numerous licensed seasonal influenza vaccines. The rising demand for vaccine is anticipated to surge the global influenza vaccine market.

Analyst View:

Increasing investment and the growing government funding have boosted research and development of pharmaceutical companies which drives the market. Growing demand for pediatric vaccine as highest market size is covered among the age group. Quadrivalent vaccines are in great demands as they protect from four strains of the influenza virus through a single vaccine which boost the market of flu vaccine.

Browse 60 market data tables* and 35 figures* through 140 slides and in-depth TOC on “Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

The report " Global Flu Vaccine Market, By Type (Split Virus Vaccines, Subunit Vaccines, and Others), By Application (For Children and For Adults and Children over 3 years), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030”

To know the upcoming trends and insights prevalent in this market, click the link below:

https://www.prophecymarketinsights.com/market_insight/Global-Flu-Vaccine-Market-By-2230

Competitive Landscape:

The key players operating in the Global Flu Vaccine Market include CSL Itd, GSK LLc, Sanofi Pasteur, Mylan N.V., AstraZeneca PLC, Pfizer Inc., and Johnson & Johnson Company.

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Key Highlights:

In 2020, Abbott launched a new inactivated quadrivalent vaccine for influenza, first of its kind sub-unit vaccine offering protection against this strains in India. Approved vaccine is for below 3 years.
In August 2020, AstraZeneca increases its manufacturing effects to deliver more FluMIST by collaborating with top key players such as GlaxoSmithKline, Sanofi, Seqirus in efforts to increase the manufacturing of vaccine
Key Market Insights from the report:

The Global Flu Vaccine Market accounted for US$ 4572.3 million in 2020 and is estimated to be US$ 8179.4 million by 2030 and is anticipated to register a CAGR of 6.0%. The Global Flu Vaccine Market is segmented based on the type, application and region.

By Type, the Global Flu Vaccine Market is segmented into Split Virus Vaccines, Subunit Vaccines, and Others
By Application, the market is segmented in For Children and For Adults and Children over 3 years
By region, the Global Flu Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
About Prophecy Market Insights

Prophecy Market Insights is specialized market research, analytics, marketing/business strategy, and solutions that offers strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high-value opportunities in the target business area. We also help our clients to address business challenges and provide the best possible solutions to overcome them and transform their business.

Some Important Points Answered in this Market Report Are Given Below:

Explains an overview of the product portfolio, including product development, planning, and positioning
Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
Detailed analysis of the market revenue over the forecasted period.
Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
Study on the segments that are anticipated to dominate the market.
Study on the regional analysis that is expected to register the highest growth over the forecast period
Key Topics Covered

Introduction
Study Deliverables
Study Assumptions
Scope of the Study
Research Methodology
Executive Summary
Opportunity Map Analysis
Market at Glance
Market Share (%) and BPS Analysis, by Region
Competitive Landscape
Heat Map Analysis
Market Presence and Specificity Analysis
Investment Analysis
Competitive Analysis
To know more

Contact Us:

Sales

Prophecy Market Insights

1 860 531 2701

Email- [email protected]
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By prophecy
Phone 91 7775049802
Country United States
Categories Biotech , Health , Marketing
Tags global flu vaccine market , global flu vaccine market forecast , global flu vaccine market research
Last Updated December 6, 2021